New MRI techniques aim to reveal hidden tumor details
NCT ID NCT03483337
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing new MRI techniques to get more detailed images of head and neck and thyroid cancers. About 200 adults will have extra MRI scans before, during, or after treatment. The goal is to see if these scans can provide early clues about how well a treatment is working.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- MRI examinations
- What this could lead to
- If successful, this could lead to better ways to see how tumors respond to treatment using MRI, helping doctors make more informed decisions.
- What could go wrong
- This is an early imaging study, not a treatment trial. The new MRI methods may not provide useful information beyond standard scans, and results may not change patient care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Genetic test may spare patients from unnecessary thyroid surgery
- Can a new oral drug outsmart Radioiodine-Resistant thyroid cancer?
- Can tailored nutrition boost recovery from head and neck surgery?
- Can less radiation be safer for throat cancer?
- Can an immune booster make radioiodine more effective against thyroid cancer?
- Hidden thyroid cancers may be more common in Graves' disease than thought